A dual role for the N-terminal domain of the IL-3 receptor in cell signalling

被引:33
作者
Broughton, Sophie E. [1 ]
Hercus, Timothy R. [2 ,3 ]
Nero, Tracy L. [1 ]
Kan, Winnie L. [2 ,3 ]
Barry, Emma F. [2 ,3 ]
Dottore, Mara [2 ,3 ]
Shing, Karen S. Cheung Tung [1 ,4 ]
Morton, Craig J. [1 ]
Dhagat, Urmi [1 ]
Hardy, Matthew P. [5 ]
Wilson, Nicholas J. [5 ]
Downton, Matthew T. [6 ]
Schieber, Christine [6 ]
Hughes, Timothy P. [7 ,8 ]
Lopez, Angel F. [2 ,3 ]
Parker, Michael W. [1 ,4 ]
机构
[1] St Vincents Inst Med Res, Australian Canc Res Fdn, Rat Drug Discovery Ctr, Fitzroy, Vic 3065, Australia
[2] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia
[3] Univ South Australia, Adelaide, SA 5000, Australia
[4] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia
[5] CSL Ltd, Parkville, Vic 3010, Australia
[6] IBM Res Australia, Level 5,204 Lygon St, Carlton, Vic 3053, Australia
[7] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia
[8] Univ Adelaide, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
ACUTE MYELOID-LEUKEMIA; COLONY-STIMULATING FACTOR; HIGH-AFFINITY BINDING; COMMON BETA-CHAIN; ACUTE MYELOGENOUS LEUKEMIA; HUMAN INTERLEUKIN-3; STEM-CELLS; GM-CSF; MOLECULAR-DYNAMICS; ALPHA-CHAIN;
D O I
10.1038/s41467-017-02633-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interleukin-3 (IL-3) receptor is a cell-surface heterodimer that links the haemopoietic, vascular and immune systems and is overexpressed in acute and chronic myeloid leukaemia progenitor cells. It belongs to the type I cytokine receptor family in which the alpha-subunits consist of two fibronectin III-like domains that bind cytokine, and a third, evolutionarily unrelated and topologically conserved, N-terminal domain (NTD) with unknown function. Here we show by crystallography that, while the NTD of IL3R alpha is highly mobile in the presence of IL-3, it becomes surprisingly rigid in the presence of IL-3 K116W. Mutagenesis, biochemical and functional studies show that the NTD of IL3R alpha regulates IL-3 binding and signalling and reveal an unexpected role in preventing spontaneous receptor dimerisation. Our work identifies a dual role for the NTD in this cytokine receptor family, protecting against inappropriate signalling and dynamically regulating cytokine receptor binding and function.
引用
收藏
页数:15
相关论文
共 66 条
[1]   Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform [J].
Al-Hussaini, Muneera ;
Rettig, Michael P. ;
Ritchey, Julie K. ;
Karpova, Darja ;
Uy, Geoffrey L. ;
Eissenberg, Linda G. ;
Gao, Feng ;
Eades, William C. ;
Bonvini, Ezio ;
Chichili, Gurunadh R. ;
Moore, Paul A. ;
Johnson, Syd ;
Collins, Lynne ;
DiPersio, John F. .
BLOOD, 2016, 127 (01) :122-131
[2]   In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent [J].
Angelot-Delettre, Fanny ;
Roggy, Anne ;
Frankel, Arthur E. ;
Lamarthee, Baptiste ;
Seilles, Estelle ;
Biichle, Sabeha ;
Royer, Bernard ;
Deconinck, Eric ;
Rowinsky, Eric K. ;
Brooks, Christopher ;
Bardet, Valerie ;
Benet, Blandine ;
Bennani, Hind ;
Benseddik, Zehaira ;
Debliquis, Agathe ;
Lusina, Daniel ;
Roussel, Mikael ;
Solly, Francoise ;
Ticchioni, Michel ;
Saas, Philippe ;
Garnache-Ottou, Francine .
HAEMATOLOGICA, 2015, 100 (02) :223-230
[3]   Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone φ, ψ and Side-Chain χ1 and χ2 Dihedral Angles [J].
Best, Robert B. ;
Zhu, Xiao ;
Shim, Jihyun ;
Lopes, Pedro E. M. ;
Mittal, Jeetain ;
Feig, Michael ;
MacKerell, Alexander D., Jr. .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (09) :3257-3273
[4]   Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling [J].
Broughton, Sophie E. ;
Hercus, Timothy R. ;
Nero, Tracy L. ;
Dottore, Mara ;
McClure, Barbara J. ;
Dhagat, Urmi ;
Taing, Houng ;
Gorman, Michael A. ;
King-Scott, Jack ;
Lopez, Angel F. ;
Parker, Michael W. .
STRUCTURE, 2016, 24 (08) :1271-1281
[5]   Dual Mechanism of Interleukin-3 Receptor Blockade by an Anti-Cancer Antibody [J].
Broughton, Sophie E. ;
Hercus, Timothy R. ;
Hardy, Matthew P. ;
McClure, Barbara J. ;
Nero, Tracy L. ;
Dottore, Mara ;
Huynh, Huy ;
Braley, Hal ;
Barry, Emma F. ;
Kan, Winnie L. ;
Dhagat, Urmi ;
Scotney, Pierre ;
Hartman, Dallas ;
Busfield, Samantha J. ;
Owczarek, Catherine M. ;
Nash, Andrew D. ;
Wilson, Nicholas J. ;
Parker, Michael W. ;
Lopez, Angel F. .
CELL REPORTS, 2014, 8 (02) :409-418
[6]   Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362 [J].
Broughton, Sophie E. ;
Hercus, Timothy R. ;
Nero, Tracy L. ;
Dhagat, Urmi ;
Owczarek, Catherine M. ;
Hardy, Matthew P. ;
Fabri, Louis J. ;
Scotney, Pierre D. ;
Nash, Andrew D. ;
Wilson, Nicholas J. ;
Lopez, Angel F. ;
Parker, Michael W. .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2014, 70 :358-361
[7]   The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling [J].
Broughton, Sophie E. ;
Dhagat, Urmi ;
Hercus, Timothy R. ;
Nero, Tracy L. ;
Grimbaldeston, Michele A. ;
Bonder, Claudine S. ;
Lopez, Angel F. ;
Parker, Michael W. .
IMMUNOLOGICAL REVIEWS, 2012, 250 :277-302
[8]   Model for growth hormone receptor activation based on subunit rotation within a receptor dimer [J].
Brown, RJ ;
Adams, JJ ;
Pelekanos, RA ;
Wan, Y ;
McKinstry, WJ ;
Palethorpe, K ;
Seeber, RM ;
Monks, TA ;
Eidne, KA ;
Parker, MW ;
Waters, MJ .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (09) :814-821
[9]   HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia [J].
Brumatti, Gabriela ;
Salmanidis, Marika ;
Kok, Chung H. ;
Bilardi, Rebecca A. ;
Sandow, Jarrod J. ;
Silke, Natasha ;
Mason, Kylie ;
Visser, Jolanda ;
Jabbour, Anissa M. ;
Glaser, Stefan P. ;
Okamoto, Toru ;
Bouillet, Philippe ;
D'Andrea, Richard J. ;
Ekert, Paul G. .
ONCOTARGET, 2013, 4 (11) :1933-1947
[10]   Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC [J].
Busfield, S. J. ;
Biondo, M. ;
Wong, M. ;
Ramshaw, H. S. ;
Lee, E. M. ;
Ghosh, S. ;
Braley, H. ;
Panousis, C. ;
Roberts, A. W. ;
He, S. Z. ;
Thomas, D. ;
Fabri, L. ;
Vairo, G. ;
Lock, R. B. ;
Lopez, A. F. ;
Nash, A. D. .
LEUKEMIA, 2014, 28 (11) :2213-2221